BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37099781)

  • 1. Role of Immunohistochemistry in Suspected Pancreatic Ductal Adenocarcinoma: A Prospective Study on Fine Needle Aspiration Biopsies.
    Valentini AM; Savino MT; Donghia R; Schena N; Arborea G
    Pancreas; 2022 Nov-Dec 01; 51(10):1372-1375. PubMed ID: 37099781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of S100p, IMP3, Maspin, and pVHL in the Differantial Diagnosis of Pancreatic Ductal Adenocarcinoma and Normal/chronic Pancreatitis in Fine Needle Aspiration Biopsy.
    Aksoy-Altinboga A; Baglan T; Umudum H; Ceyhan K
    J Cytol; 2018; 35(4):247-251. PubMed ID: 30498299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
    Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
    Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. True diagnostic ability of EUS-guided fine-needle aspiration/biopsy sampling for small pancreatic lesions ≤10 mm and salvage diagnosis by pancreatic juice cytology: a multicenter study.
    Sagami R; Nakahodo J; Minami R; Yamao K; Yoshida A; Nishikiori H; Takenaka M; Mizukami K; Murakami K
    Gastrointest Endosc; 2024 Jan; 99(1):73-80. PubMed ID: 37598865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma.
    Wachter DL; Schlabrakowski A; Hoegel J; Kristiansen G; Hartmann A; Riener MO
    Am J Surg Pathol; 2011 Jun; 35(6):873-7. PubMed ID: 21566520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of pVHL, maspin, IMP3, S100P and Ki67 in the distinction of autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Hedegaard Jensen G; Mortensen MB; Klöppel G; Nielsen MFB; Nielsen O; Detlefsen S
    Pathol Res Pract; 2020 May; 216(5):152925. PubMed ID: 32273198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma.
    Eloubeidi MA; Jhala D; Chhieng DC; Chen VK; Eltoum I; Vickers S; Mel Wilcox C; Jhala N
    Cancer; 2003 Oct; 99(5):285-92. PubMed ID: 14579295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens.
    Yu S; Doyle LA; Hornick JL; Mito JK
    Cancer Cytopathol; 2024 Feb; 132(2):87-95. PubMed ID: 38054349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of endoscopic ultrasound-guided fine needle aspiration in pretest prediction and diagnosis of pancreatic ductal adenocarcinoma].
    Wu L; Guo W; Li Y; Cheng T; Yao Y; Zhang Y; Liu B; Zhong M; Li S; Deng X; Zhu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1171-1178. PubMed ID: 30377133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUS - Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis of Pancreatic Adenocarcinoma: A Review.
    Kalogeraki A; Papadakis GZ; Tamiolakis D; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Papadakis M; Moustou E; Datseri G; Tzardi M
    Rom J Intern Med; 2016; 54(1):24-30. PubMed ID: 27141567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology.
    Kosarac O; Takei H; Zhai QJ; Schwartz MR; Mody DR
    Acta Cytol; 2011; 55(2):142-8. PubMed ID: 21325798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic cancer: A retrospective study.
    Yoshizawa N; Yamada R; Sakuno T; Inoue H; Miura H; Takeuchi T; Nakamura M; Hamada Y; Katsurahara M; Tanaka K; Horiki N; Takei Y
    Medicine (Baltimore); 2018 Jun; 97(24):e11096. PubMed ID: 29901627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.
    Bournet B; Pointreau A; Souque A; Oumouhou N; Muscari F; Lepage B; Senesse P; Barthet M; Lesavre N; Hammel P; Levy P; Ruszniewski P; Cordelier P; Buscail L
    Pancreatology; 2012; 12(1):27-34. PubMed ID: 22487470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of calcifications on diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma.
    Koshy AK; Harshavardhan RB; Siyad I; Venu RP
    Indian J Gastroenterol; 2019 Apr; 38(2):128-133. PubMed ID: 30903611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens.
    Deng H; Shi J; Wilkerson M; Meschter S; Dupree W; Lin F
    Am J Clin Pathol; 2008 Jan; 129(1):81-8. PubMed ID: 18089492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
    Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
    Wiktorowicz M; Mlynarski D; Pach R; Tomaszewska R; Kulig J; Richter P; Sierzega M
    Pancreatology; 2018 Dec; 18(8):977-982. PubMed ID: 30268674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasound-guided fine needle biopsy specimens: an interobserver agreement study.
    Notohara K; Kamisawa T; Furukawa T; Fukushima N; Uehara T; Kasashima S; Iwasaki E; Kanno A; Kawashima A; Kubota K; Kuraishi Y; Motoya M; Naitoh I; Nishino T; Sakagami J; Shimizu K; Tomono T; Aishima S; Fukumura Y; Hirabayashi K; Kojima M; Mitsuhashi T; Naito Y; Ohike N; Tajiri T; Yamaguchi H; Fujiwara H; Ibuki E; Kobayashi S; Miyaoka M; Nagase M; Nakashima J; Nakayama M; Oda S; Taniyama D; Tsuyama S; Watanabe S; Ikeura T; Kawa S; Okazaki K
    Virchows Arch; 2022 Mar; 480(3):565-575. PubMed ID: 34820715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Equilibrative Nucleoside Transporter 1 Expression in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration Biopsy Samples Is a Strong Predictor of Clinical Response and Survival in the Patients With Pancreatic Ductal Adenocarcinoma Undergoing Gemcitabine-Based Chemoradiotherapy.
    Yamada R; Mizuno S; Uchida K; Yoneda M; Kanayama K; Inoue H; Murata Y; Kuriyama N; Kishiwada M; Usui M; Ii N; Tsuboi J; Tano S; Hamada Y; Tanaka K; Horiki N; Ogura T; Shiraishi T; Takei Y; Katayama N; Isaji S
    Pancreas; 2016; 45(5):761-71. PubMed ID: 26784908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.